From the outset, the study highlights the limitations that conventional methods face in controlling protein expression through RNA constructs. Since protein production is a pivotal step in therapeutic efficacy, the ability to fine-tune translation initiation independent of the cellular cap-binding machinery offers a strategic advantage. The research calls attention to IRES as versatile molecular tools because they enable translation initiation without relying on the 5’ cap structure typically required by eukaryotic ribosomes. Yet, the complexity of natural IRES sequences, which interact with a myriad of RNA-binding proteins and possess elaborate three-dimensional conformations, necessitates sophisticated computational tools for reliable identification and design.

Central to this advancement is IRES-LM, an innovative language model ensemble comprised of two deeply trained natural language processing architectures. Trained on an extensive dataset of over 46,000 sequences, IRES-LM surpasses previous benchmark methods by achieving a 15% improvement in critical performance metrics such as the area under the curve (AUC) and F1 score. This improvement is not merely incremental but signifies a robust leap in the capacity to accurately predict linear mRNA IRES elements, which are pivotal in therapeutic mRNA design. Impressively, IRES-LM also showcases remarkable versatility by demonstrating strong cross-applicability to circular RNA IRES identification, correctly pinpointing all 21 experimentally verified circular RNA IRES elements—a feat that existing tools struggled to achieve.

Building upon this predictive prowess, the research team integrated an evolutionary algorithm with IRES-LM, resulting in the creation of IRES-EA. This synergistic approach harnesses targeted mutagenesis guided by AI predictions to drive the conversion of non-IRES sequences into functional IRES elements. The scale of this approach is staggering: computational analyses of over 37,000 sequences initially lacking IRES functionality predicted a 60% success rate in functional conversion. These computational predictions were backed by experimental validation through massively parallel reporter assays involving 12,000 mutated sequences, revealing a remarkable 98.4% acquisition of IRES activity. This convergence of in silico prediction and wet-lab validation underscores the framework’s ability to induce precise functional transformations efficiently.

Extending the frontier even further, the researchers introduced IRES-DM, a diffusion model designed to generate novel IRES sequences de novo. Unlike evolutionary optimization, which works incrementally, IRES-DM creates entirely new sequences from fundamental principles encoded in the trained model. This generative capability has major implications for synthetic biology, where creating unique, tailored RNA elements can circumvent natural sequence limitations. Validated by another extensive massively parallel reporter assay involving 12,000 AI-generated sequences, 99.3% exhibited detectable IRES function, thereby establishing de novo generation as an effective and reliable avenue for RNA element design.

A compelling feature of IRES-DM’s generative capacity is its ability to produce a diverse range of sequence variants. It can generate sequences that mirror natural IRES candidates as well as structurally conserved sequences that diverge significantly at the nucleotide sequence level. This balance between biomimicry and innovation is crucial for applications that demand both predictability and novelty in RNA design. Structural conservation is particularly significant because it underlies the functional integrity of IRES elements, highlighting the model’s sophisticated grasp of structure-function relationships.

The study also delves into motif analysis to dissect the essential building blocks underpinning IRES activity. By mining both natural and AI-generated sequence pools, researchers identified motifs highly enriched in functional IRES elements. Some motifs are prevalent in naturally occurring sequences, while others emerge predominantly in AI-designed sequences with high IRES activity. This insight not only aids in understanding the molecular grammar of translation initiation but also guides future rational design and synthetic biology efforts by pinpointing key RNA features to embed in engineered constructs.

The fusion of deep learning and evolutionary algorithms presented in this work exemplifies the potential of AI to accelerate biomedical discovery. The framework’s integrated strategy—from identification to optimization, and finally de novo generation—offers a scalable solution to one of the biggest hurdles in RNA therapeutic development: modulating translation with precision. It effectively transforms the longstanding challenge of deciphering IRES’s complex structure-function interplay into a programmable, user-driven process.

Moreover, the broad applicability of this framework to both linear and circular RNA modalities expands its utility across diverse RNA therapeutic platforms. Circular RNAs, which are gaining traction due to their enhanced stability and translational potential, previously suffered from limited tools for IRES characterization. By addressing this gap, the AI framework paves the way for next-generation RNA therapeutics with superior efficacy and durability.

This research also holds promise beyond therapeutics, offering synthetic biologists a new suite of tools for the design of custom RNA elements for biosensors, gene circuits, and synthetic protein expression systems. The ability to program translation through AI-directed sequence design could transform the speed and accuracy with which synthetic biological systems are engineered and optimized.

Emphasizing the interplay between computational and experimental sciences, the extensive massively parallel reporter assays employed in this study validate the models’ predictions at an unprecedented scale. This experimental rigor ensures that the AI-generated sequences are not just theoretically appealing but functionally robust in cellular contexts, addressing a common pitfall in computational biology.

As RNA-based medicines continue to expand their footprint in treating cancers, genetic disorders, and infectious diseases, the technological leap demonstrated by this AI framework offers a transformative platform. By bridging the knowledge gap in IRES biology and enabling precise, scalable control over RNA translation, it sets the stage for a new era of personalized, programmable RNA therapeutics.

Ultimately, this work exemplifies the power of artificial intelligence to decode and harness complex biological information, translating it into practical tools that can reshape biomedicine. The researchers’ accomplishment in unifying IRES identification, optimization, and de novo design into a single, cohesive framework heralds a new chapter in RNA science, where computational ingenuity accelerates discovery and innovation.

Subject of Research:
Article Title:
Article References:

Chu, Y., Yin, D., Yu, D. et al. Programmable RNA translation through deep learning-driven IRES discovery and de novo generation.
Nat Mach Intell 8, 559–574 (2026). https://doi.org/10.1038/s42256-026-01213-z

Image Credits: AI Generated

DOI: April 2026

Keywords: RNA therapeutics, internal ribosome entry sites, IRES identification, IRES optimization, de novo RNA design, deep learning, language models, evolutionary algorithms, diffusion models, massively parallel reporter assays, synthetic biology, programmable translation, circular RNA, artificial intelligence

Stress granules are dynamic, membraneless organelles that transiently form in response to various cellular stressors such as oxidative stress, heat shock, and viral infections. These ribonucleoprotein aggregates serve as critical hubs for the sequestration and triage of untranslated mRNAs and associated proteins, effectively modulating gene expression and maintaining proteostasis under adverse conditions. Dysregulation of stress granule dynamics has been implicated in the pathogenesis of numerous neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and BPAN, which is characterized by mutations in the WDR45 gene.

The protein WDR45 belongs to the WD-repeat protein family and features a distinctive β-propeller structural motif that facilitates protein-protein interactions and scaffolding functions within the cell. Mutation-induced dysfunctions in WDR45 have been previously shown to disrupt autophagic flux and mitochondrial homeostasis, linking WDR45 defects to neurodegeneration. However, the molecular underpinnings governing WDR45’s role in stress granule biology remained largely unexplored until this pioneering work.

Li and colleagues employed an integrative approach combining biochemical assays, advanced imaging techniques, and phase separation experiments to dissect how WDR45 influences stress granule turnover. Their data compellingly demonstrate that WDR45 participates directly in stress granule disassembly by engaging in liquid-liquid phase separation (LLPS) with Caprin-1, a well-established RNA-binding protein and stress granule nucleator. This WDR45-Caprin-1 interaction facilitates the formation of a dynamic biomolecular condensate that destabilizes stress granules, promoting the release of sequestered mRNAs and proteins and thereby restoring normal cellular homeostasis.

Phase separation has emerged in recent years as a fundamental mechanism by which cells organize their internal milieu without membrane-bound compartments. Through LLPS, proteins and nucleic acids can coalesce into concentrated assemblies, enabling rapid and reversible compartmentalization. The ability of WDR45 to partake in such phase transitions in collaboration with Caprin-1 suggests a previously unrecognized layer of regulation in stress granule dynamics and highlights phase separation as a critical coordinator of neuroprotective pathways.

Intriguingly, the study further reveals that disease-associated mutations in WDR45 impair its propensity for phase separation and interaction with Caprin-1, resulting in defective stress granule clearance. Using point mutations identified in BPAN patients, the researchers showed that mutant WDR45 proteins form aberrant aggregates rather than dynamic condensates, thereby trapping stress granules and exacerbating cellular stress. These findings provide a direct molecular link between WDR45’s phase separation capability and the pathological accumulation of stress granules observed in neurodegenerative diseases.

Advanced super-resolution microscopy allowed the team to visualize the spatial-temporal dynamics of WDR45 and Caprin-1 within live cells undergoing stress. The data uncovered that WDR45 localizes transiently to the periphery of Caprin-1-enriched stress granules, likely acting as a molecular buffer to facilitate granule disassembly. This nuanced localization pattern underscores the functional specificity by which WDR45 contributes to stress granule resolution and distinguishes it from other canonical autophagic adaptor proteins.

Beyond the mechanistic insights, the implications of this work extend to potential therapeutic interventions. The modulation of phase separation properties of WDR45 or stabilization of its interaction with Caprin-1 could be harnessed to enhance stress granule clearance in the context of neurodegeneration. Small molecules or biologics aimed at restoring WDR45’s normal function may mitigate the cytotoxic accumulation of stress granules and ameliorate disease progression in BPAN and related disorders.

The study also raises intriguing questions about the broader role of phase separation in the orchestration of cellular proteostasis networks. It remains to be determined whether WDR45 participates in similar condensate dynamics in other cellular pathways or interacts with additional RNA-binding proteins involved in stress responses. Further investigations into the biophysical principles governing WDR45-mediated condensate formation could unveil novel regulatory mechanisms relevant across diverse neurodegenerative conditions.

Moreover, the discovery that WDR45 mutations disrupt phase separation dynamics prompts reconsideration of how protein mutations contribute to disease beyond mere loss of function. Aberrant phase separation and the resultant dysregulated condensates appear increasingly recognized as a pathogenic theme in neurodegeneration, opening new avenues for diagnostics and targeted therapies centered on biophysical properties of proteins.

The extensive use of cutting-edge biophysical methods—ranging from fluorescence recovery after photobleaching (FRAP) to in vitro droplet assays—lent robust support to the conclusions of this study. This comprehensive toolkit allowed the authors to capture phase separation behaviors at molecular resolution and link structural perturbations in WDR45 to functional deficits in stress granule disassembly.

Importantly, the cross-disciplinary collaboration underlying this research, spanning molecular biology, biophysics, and neurobiology, exemplifies the power of integrative science to uncover novel disease mechanisms. By bridging fundamental protein chemistry with cellular pathophysiology, the study advances our understanding of how subtle alterations in protein properties can precipitate complex neurodegenerative syndromes.

Looking forward, this work sets the stage for exploring phase separation-targeted pharmacology as a promising avenue for treating BPAN and potentially other protein aggregation disorders. It also calls for expanded genetic screening of neurodegenerative patients focusing on proteins implicated in condensate biology, which may reveal additional players akin to WDR45 with therapeutic relevance.

This landmark investigation illuminates the delicate balance cells must maintain to navigate stress and preserve functional proteomes. By unveiling WDR45 as a pivotal regulator of stress granule dynamics via phase separation with Caprin-1, Li and colleagues have charted a compelling narrative that transforms our understanding of neurodegeneration and opens fresh horizons for scientific inquiry and clinical innovation.

Subject of Research: β-Propeller protein-associated neurodegeneration protein WDR45’s role in stress granule disassembly via phase separation with Caprin-1

Article Title: β-propeller protein-associated neurodegeneration protein WDR45 regulates stress granule disassembly via phase separation with Caprin-1

Article References:
Li, Y., Fang, J., Ding, Y. et al. β-propeller protein-associated neurodegeneration protein WDR45 regulates stress granule disassembly via phase separation with Caprin-1. Nat Commun 16, 5227 (2025). https://doi.org/10.1038/s41467-025-60583-x

Image Credits: AI Generated